GSK 525762A,
GSK-525762A,
GSK525762,
GSK525762A,
I-BET compound,
I-BET762,
IBET compound,
1260907-17-2,
GSK 525762A,
I-BET-762,
molibresib,
GSK525762A,
GSK525762,
I-BET762,
UNII-5QIO6SRZ2R,
GSK-525762,
I-BET 762,
5QIO6SRZ2R,
(S)-2-(6-(4-Chlorophenyl)-8-methoxy-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepin-4-yl)-N-ethylacetamide,
CHEMBL1232461,
GSK-525762A,
2-[(4s)-6-(4-Chlorophenyl)-8-Methoxy-1-Methyl-4h-[1,2,4]triazolo[4,3-A][1,4]benzodiazepin-4-Yl]-N-Ethylacetamide,
CS-0717,
GSK-525762A (I-BET 762),
(S)-2-(6-(4-Chlorophenyl)-8-methoxy-1-methyl-4H-benzo-[f][1,2,4]triazolo[4,3-a][1,4]diazepin-4-yl)-N-ethylacetamide,
Bet inhibitor GSK525762,
2yek,
iBET,
EAM,
3p5o,
GTPL7033,
SCHEMBL1872390,
CHEBI:95082,
AOB2188,
DTXSID60677590,
EX-A462,
AAAQFGUYHFJNHI-SFHVURJKSA-N,
BCP07337,
KS-00001D3G,
BDBM50365463,
MFCD22417091,
s7189,
ZINC58655571,
AKOS025404837,
ACN-030386,
CCG-208698,
SB16743,
NCGC00263621-02,
NCGC00263621-04,
AS-16364,
BC600500,
HY-13032,
QC-11690,
GSK-525762A(I-BET-762),
I-BET762, >=98% (HPLC),
B1498,
FT-0700437,
SW220225-1,
Y1399,
A11440,
W-5923,
J-005327,
2-[(4S)-6-(4-Chlorophenyl)-1-methyl-8-(methyloxy)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethylacetamide,
4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine-4-acetamide, 6-(4-chlorophenyl)-N-ethyl-8-methoxy-1-methyl-, (4S)-,
IBET compound,
I-BET compound,
D07OFM,
C22H22ClN5O2,
GSK2838232A,
C554645,
1443461-21-9,